CN105769804B - 一种阿法替尼片及其制备方法 - Google Patents
一种阿法替尼片及其制备方法 Download PDFInfo
- Publication number
- CN105769804B CN105769804B CN201410829357.0A CN201410829357A CN105769804B CN 105769804 B CN105769804 B CN 105769804B CN 201410829357 A CN201410829357 A CN 201410829357A CN 105769804 B CN105769804 B CN 105769804B
- Authority
- CN
- China
- Prior art keywords
- afatinib
- mannitol
- maleate
- piece
- mentioned
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410829357.0A CN105769804B (zh) | 2014-12-23 | 2014-12-23 | 一种阿法替尼片及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201410829357.0A CN105769804B (zh) | 2014-12-23 | 2014-12-23 | 一种阿法替尼片及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN105769804A CN105769804A (zh) | 2016-07-20 |
CN105769804B true CN105769804B (zh) | 2019-04-30 |
Family
ID=56388666
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201410829357.0A Active CN105769804B (zh) | 2014-12-23 | 2014-12-23 | 一种阿法替尼片及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN105769804B (zh) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN107260698B (zh) * | 2017-06-28 | 2018-02-23 | 广东安诺药业股份有限公司 | 一种马来酸阿法替尼片的制备方法 |
CN110693846B (zh) * | 2018-07-10 | 2021-07-27 | 杭州华东医药集团新药研究院有限公司 | 迈华替尼药物组合物及其制备方法 |
CN110833534B (zh) * | 2018-08-15 | 2022-10-25 | 四川科伦药物研究院有限公司 | 马来酸阿法替尼片剂及其制备方法 |
CN114452290A (zh) * | 2022-02-15 | 2022-05-10 | 上海龙翔生物医药开发有限公司 | 一种抗肿瘤药物阿法替尼的合成方法 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102056589A (zh) * | 2008-06-06 | 2011-05-11 | 贝林格尔.英格海姆国际有限公司 | 包含bibw 2992的固体药物制剂 |
-
2014
- 2014-12-23 CN CN201410829357.0A patent/CN105769804B/zh active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN102056589A (zh) * | 2008-06-06 | 2011-05-11 | 贝林格尔.英格海姆国际有限公司 | 包含bibw 2992的固体药物制剂 |
Also Published As
Publication number | Publication date |
---|---|
CN105769804A (zh) | 2016-07-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN105769804B (zh) | 一种阿法替尼片及其制备方法 | |
JP5285105B2 (ja) | 医薬品組成物 | |
WO2015185013A1 (zh) | 包含喹啉衍生物或其盐的药物组合物及其制备方法 | |
ZA200502693B (en) | Pharmaceutical excipients comprising inorganic particles in association with an organic polymeric material and forming a solid reticulated matrix, compositions, manufacturing and use thereof. | |
KR20130060221A (ko) | 장용성 정제 | |
CN112220770B (zh) | 司来帕格的药物组合物及其制备方法 | |
CN106913529B (zh) | 一种来那替尼或其可药用盐药物组合物的制备方法 | |
JP5787881B2 (ja) | 腸溶性錠剤 | |
WO2020098795A1 (en) | Pharmaceutical preparation of fruquintinib and use thereof | |
JP6585193B2 (ja) | ゲフィチニブ含有錠剤 | |
CN104138380A (zh) | 厄洛替尼或其可药用盐的组合物及其制备方法和用途 | |
WO2018153379A1 (zh) | 一种2-氨基嘧啶类化合物的药用组合物及其制备方法 | |
CN110520110A (zh) | 包含5-氯-n4-[2-(二甲基磷酰基)苯基]-n2-{2-甲氧基-4-[4-(4-甲基哌嗪-1-基)哌啶-1-基]苯基}嘧啶-2,4-二胺的药物制剂 | |
CN104398482B (zh) | 应用复合乳糖的吲达帕胺缓释药物 | |
CN103720672B (zh) | 孟鲁司特钠咀嚼片及其粉末直接压片制备方法 | |
CN107530331B (zh) | 一种含有吡咯并六元杂环化合物或其可药用盐的药物组合物 | |
CN114306271B (zh) | 一种仑伐替尼组合物 | |
CN110856719B (zh) | 一种2-氨基嘧啶类化合物的药用组合物 | |
CN113116840B (zh) | 一种硫酸羟氯喹片的制备方法 | |
CN113750059B (zh) | 一种迈华替尼片剂及其制备方法 | |
WO2019130701A1 (ja) | セルロース粉末 | |
CN107744508A (zh) | 一种氢溴酸加兰他敏片剂 | |
CN104337783B (zh) | 一种卡培他滨片剂及其制备方法 | |
WO2022042646A1 (zh) | 盐酸鲁拉西酮组合物及其制备方法 | |
WO2021136089A1 (zh) | 一种抗肿瘤药物组合物以及提高化合物的溶解度的方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
CB02 | Change of applicant information |
Address after: 201210 Zhang Heng Road, 1999, China (Shanghai) free trade test area, No. 1999 Applicant after: Shanghai Xingtai Pharmaceutical Technology Co., Ltd. Address before: 201203 Shanghai city Pudong New Area Bing Road No. 306 building 3 floor No. 1 Applicant before: SHANGHAI SUNTECH PHARMACEUTICAL CO., LTD. |
|
CB02 | Change of applicant information | ||
CI02 | Correction of invention patent application |
Correction item: Applicant|Address Correct: Shanghai Double Star Thai Pharmaceutical Technology Co., Ltd.|201210 Zhang Heng Road, 1999, China (Shanghai) free trade test area, No. 1999 False: Shanghai Xingtai Pharmaceutical Technology Co., Ltd.|201210 Zhang Heng Road, 1999, China (Shanghai) free trade test area, No. 1999 Number: 49-02 Volume: 33 |
|
CI02 | Correction of invention patent application | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20210326 Address after: 201210 building 7, 1999 zhangheng Road, China (Shanghai) pilot Free Trade Zone, Pudong New Area, Shanghai Patentee after: SHANGHAI FOSUN XINGTAI PHARMA TECHNOLOGY Co.,Ltd. Patentee after: JIANGSU WANBANG BIOPHARMACEUTICAL GROUP Co.,Ltd. Address before: Building 7, 1999 zhangheng Road, China (Shanghai) pilot Free Trade Zone, 201210 Patentee before: SHANGHAI FOSUN XINGTAI PHARMA TECHNOLOGY Co.,Ltd. |
|
TR01 | Transfer of patent right |